Emily Passer

PR/Comms, @noom. Formerly: @pagayaltd, @nbcnews, @qz, @FT. Sunglasses junkie, candy enthusiast, Rock Chalk. Views are my own. [email protected]

[Emily Passer @EmilyPasser]

I'm thrilled to share that I've started as head of communications for @noom, a company sitting at the intersection of health, technology and human behavior and with the power to deeply influence the broader health landscape. 3/4

[Noom @noom]

Noom CEO @geoffcook is heading to the @ftlive x @endpts US Pharma & Biotech Summit on May 14, speaking on a panel tackling longevity medicine's biggest questions: what's driving innovation, where investment is going, and whether it's reaching the people who need it most.
Learn more: https://t.co/95Cs0Og7oV #FTPharma

[Noom @noom]

Honored to be named to @TIME's inaugural TIME100 Companies: Industry Leaders list 🙌

The future of health isn't a drug or an app — it's what happens when lasting behavior change meets cutting-edge clinical care.

That's what we're building. https://t.co/L2Jem0top9

[Noom @noom]

Tomorrow, Noom HQ in Princeton hosts our inaugural Noom Talks event, starting with Pulitzer Prize-winning journalist @cduhigg. We're diving into GLP-1s and the powerful window they open for habit formation and lasting change. Stay tuned for the recap. 🎤

[Noom @noom]

🎉 Exciting news! Our Mindful Art Break feature has been nominated for @TheWebbyAwards in the Apps, Software & Immersive - Health, Wellness & Fitness category - built on the belief that a moment of awe can be a moment of healing.

Voting is open now through Thursday, April 16 at 11:59pm PDT - cast your vote here: https://t.co/r1jDPktZks

[Hims House @himshouse]

$HIMS $LLY $NVO

🚨 BREAKING: Noom is acquiring a 503A pharmacy to prepare for the peptide boom

We sat down with @GeoffCook (Noom CEO) to discuss why vertical integration is so important, how large the peptide market is going to be, and the evolving dynamics between telehealth platforms and big pharma

A great episode with one of the best CEOs in the game - thanks again, Geoff!

00:00 - Why pharma needs DTC platforms
03:03 - Noom's 90% revenue growth
05:01 - Why Noom bought Tailor Made Compounding
07:29 - The case for vertical integration
08:56 - Compounded GLP-1s aren't going anywhere
16:48 - The Hims-Novo deal
19:08 - Noom's pitch to next-gen pharma
24:24 - Peptide market sizing
25:33 - Why GLP-1 users will buy peptides first
27:22 - Ten million potential peptide patients 👀
30:09 - When will legalization happen?
31:09 - Tracking the FDA green list
34:26 - Who wins when peptides go legal?
37:58 - Why Noom won't rush peptide launch
39:33 - Geoff's BPC-157 ski injury recovery
46:42 - Expanding at-home labs past 30 biomarkers
52:47 - Noom IPO coming?!

Not financial, legal, or medical advice

[Hims House @himshouse]

🚨 Excited to announce that Noom CEO @geoffcook will be returning to the $HIMS House podcast next week

[Noom @noom]

💡 11 out of 12 people stop taking GLP-1s within a few years. GLP-1 therapy opens the door to change, but it doesn’t replace the need for sustained behavioral support.

That was the message from Noom CEO @geoffcook at the Stanford Consumer Health Summit.

Read the full story via @athletechnews 🔗 https://t.co/X6NYbR7QK7

[Emily Passer @EmilyPasser]

.@noom's CEO @geoffcook on what's next for GLP-1s: "We will see GLP-1s disrupt the supplement industry as they become the entry point for prescription-grade wellness."

Good expert roundup on where the category goes from here. 👇

[Noom @noom]

Where does the GLP-1 story go from here? 👀

In a new expert roundup on what's next for GLP-1s, industry leaders weigh in - including Noom CEO @geoffcook, who shares how this drug class may help shape the future of proactive care.

Read more: https://t.co/xeP3fPdkow

[Noom @noom]

We're honored to debut on @Newsweek's Most Trusted Brands 2026 list ✨

The article highlights how Noom continues to evolve - from habit science and GLP-1 support to biomarker testing and ongoing research - all in service of empowering everyone, everywhere to live better, longer every day.

Read the article featuring @geoffcook: https://t.co/RlPmo3Oy85

[Emily Passer @EmilyPasser]

New from @noom! Most logged foods by state: How Americans really eat... Quick questions... Missouri? Crab Rangoon? Really? Also, people of Arkansas who inputted just plain black coffee... are you okay?

https://t.co/fu4HI99KBr

[USA TODAY @USATODAY]

Noom launches a GLP-1-based, long-term, preventive health care program https://t.co/nwKvJpjksJ

[Emily Passer @EmilyPasser]

@noom I’m energized by the opportunity to help shape and share their story at such an important moment in our health culture. You can check out some more here: https://t.co/0BdclkQU2Y 4/4 :fin:

[Emily Passer @EmilyPasser]

Some *personal news* (a 🧵 🪡 )… After more than 3.5 years, I’m moving on from Pagaya, where I was incredibly grateful to have worked with some wicked smart folks, share a powerful growth story and the company's important mission of expanding financial opportunity. 1/4

[Emily Passer @EmilyPasser]

I'm thrilled to share that I've started as head of communications for @noom, a company sitting at the intersection of health, technology and human behavior and with the power to deeply influence the broader health landscape. 3/4

[Pagaya @Pagayaltd]

We've released $PGY 3Q25 #earnings.

Tune in to the call at 8:30 am ET, led by our CEO @galkrubiner, CFO Evangelos Perros, and President Sanjiv Das: https://t.co/gvk1Ex0FBu

[Pagaya @Pagayaltd]

We've released $PGY 1Q25 #earnings. Tune in to the call at 8:30 am ET, led by our CEO @galkrubiner, CFO Evangelos Perros, and President Sanjiv Das:

https://t.co/mIWJxwr9WV

[Pagaya @Pagayaltd]

Join CEO @galkrubiner, CFO Evangelos Perros, and President Sanjiv Das tomorrow at 8:30 am ET for our 1Q25 #earnings call:

https://t.co/LyKHvybIQg

$PGY

[TradeTalks @TradeTalks]

.@Nasdaq Market Intelligence Desk @Cortland_Living @Pagayaltd join @JillMalandrino on @Nasdaq #TradeTalks to discuss how consumers and the housing market are responding to the macro environment. https://t.co/WQedgsMFMc

[Gal Krubiner @galkrubiner]

Please join me tomorrow at 8:30 am ET for @Pagayaltd’s 4Q24 #earnings call. CFO Evangelos Perros, President Sanjiv Das, and I will be discussing our fourth-quarter results. $PGY